Pharmaceutical industry news

Obesity Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

Biotech’s 2026 IPOs deliver broad gains through August

CTT Pharmaceutical Holdings CEO Ryan Khouri buys $175 in stock

Clinical trials: New mRNA cancer vaccine plus Keytruda sharply improves melanoma survival

Canaccord Genuity maintains Buy on Helus Pharma, cuts target to $42

JAHA: Dos biomarcadores novedosos en sangre predicen la presencia de aterosclerosis subclínica y de eventos cardiovasculares

Presidential Leadership Series features trustee and former Takeda CEO Christophe Weber

CPC Biotech, Multiply Labs Develop Robot-Ready Cell Therapy Connector

West Pharmaceutical Services Sr. VP & Chief HR Officer Sold Shares Worth Over $2.7M

West Pharmaceutical (NYSE: WST) HR chief sells stock outside a 10b5-1 plan

European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized

New Phase 2 Clinical Trial Initiating in 2027: Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder

David Samra Calls For Novartis Board Shake-Up | PharmExec

West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day

Krystal Biotech at Cantor healthcare conference: pipeline gains pace

Fertility tests are not a reproductive crystal ball

Overview of President Trump’s Executive Actions Impacting LGBTQ+ Health

Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch

West Pharmaceutical (NYSE: WST) awards CEO 37K options and 14.8K RSUs vesting through 2031

Precision Trading with Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) Risk Zones

Quantum BioPharma Advances Multiple Sclerosis Drug Lucid-MS Toward Phase 2 Trial After FDA Clearance

Committee Will Weigh Biotech Innovation Against Security Risks

Biohaven Shares Plunge as FDA Halts New Enrollment in Epilepsy Drug Trials

Saberes que transforman: El legado vivo del Programa de Artesanía UC

Using Longitudinal Endpoint Data to Anticipate Study Complexity

Encoded secures $275m for Dravet syndrome gene therapy

FDA seeks public input on advancing botanical drug development

AbbVie Declares Quarterly Dividend

5 Best Psychedelic Stocks for 2026 and How to Invest

Chemical Structure, Formula, and Name Support Written Description of Pharmaceutical Genus

Governo quer elevar para 70% produção nacional de medicamentos até 2033, diz Alckmin no Fórum Saúde, de Esfera Brasil e EMS

Quantum BioPharma's Lucid-MS Advances Toward Phase 2 Multiple Sclerosis Trial After FDA Clearance

US FDA pauses new enrollment in Biohaven’s epilepsy drug trials

AbbVie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual Migraine

HPLC Degasser Upgraded: Biotech Fluidics Launches the DEGASi NG Platform

Pharmaceutical products with device-only patents: a cross-sectional analysis

ANMAT actualiza los criterios regulatorios para software como dispositivo médico (SaMD)

AbbVie Drug Shows Significant Reductions in Menstrual Migraine Days

Biotech news from around the world

NORD CEO Welcomes FDA Leadership Appointments, Emphasizes Stability and Innovation for Rare Diseases

FDA Clears Clinical Trial Using CAR T-Cells to Fight Colorectal Cancer

Seattle biotech BrainChild Bio raises $116M to advance CAR T therapy for childhood brain cancer

Centanafadine Receives FDA Approval for the Treatment of ADHD

NHS injury costs recovery scheme: April 2025 to March 2026

Data on the funds collected by the Compensation Recovery Unit and funds paid to the NHS.

Best Biotech Stocks To Add to Your Watchlist - September 10th

EMS marca presença pelo quinto ano no Sertões em parceria com o piloto Fábio Pirondi e busca o título inédito em 2026

XOCOVA offers new post-exposure COVID-19 prevention option for adolescents

EMS inicia sua quarta participação no Sertões com EMS Rally Team e foco no título

HSIL extends biotech index to Malaysia’s warrant market

Kala Shankle on What Comes Next for National Licensure

Minister agrees to review pharmacy amendments to Health Bill

AI Changes The How, Not The What

Accelerating Decision-Ready Hepatic PK Data: Adaptive Strategy and Integrated Execution Deliver LPE 19 Days Early

Create design controls automatically from Jira | Greenlight Guru

Roivant at Citi summit: cash-rich biotech leans on three pillars

Phase 3 trial of experimental DM1 treatment fails to hit main goal

US FDA pauses new enrollment in Biohaven's epilepsy drug trials

Burning Rock Biotech Limited Reports Earnings Results for the Second Quarter Ended June 30, 2026

US FDA pauses new enrollment in Biohaven’s epilepsy drug trials

Fifth Circuit Judges Press Louisiana on Standing as Mifepristone Stays Available by Mail with No Ruling Yet